Senescent cells exhibit a distinctive mitochondrial paradox: increased mitochondrial mass coupled with severely reduced oxidative phosphorylation efficiency. This quantity-quality imbalance destabilizes membrane potential and elevates mitochondrial reactive oxygen species, creating a self-reinforcing cycle of cellular deterioration. The dysfunction extends beyond energy production to disrupt critical organelle interactions between mitochondria, endoplasmic reticulum, and lysosomes. This framework represents a significant advance in aging research by moving beyond simplistic "mitochondrial decline" models to reveal the complex choreography of organelle dysfunction in senescence. The practical implications are substantial for longevity interventions. Current anti-aging strategies often focus on boosting mitochondrial biogenesis or enhancing antioxidant capacity in isolation. This research suggests successful senolytic therapies must address the coordinated breakdown of mitochondrial quality control systems rather than targeting single parameters. The authors' proposed standardized assay bundles could accelerate development of precision senomorphic compounds that restore mitochondrial homeostasis rather than simply increasing mitochondrial numbers. For healthy adults, this underscores the importance of interventions that maintain mitochondrial quality through exercise, caloric restriction, and compounds that enhance mitophagy rather than merely supporting mitochondrial quantity.